Redefining Early Stage of Investment (RESI)

Connecting Early Stage Products with Capital & Channel Partners

Attend Our Upcoming Events

December 4
In-person at 11 Cavendish Square

December 5-6
Virtual Partnering only

January 14
In-person at San Francisco Marriott Marquis

January 15-16, and 21
Virtual Partnering only

About RESI

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

Hear from Investors at RESI

It is our second year at RESI. In 3 days, I opened my schedule to global organizations and met efficiently online over 55 quality life sciences and medical device companies. Some are now part of our Keiretsu portfolio. I love collaborating with Resi and sourcing possible deals for our Investors’ chapters.

Daniela Tixi, Vice President at Keiretsu Forum Canada

Thank you so much for the opportunity to participate in RESI this year. It was an amazing experience presenting more about investing in mental health, psychedelics and precision psychiatry. Additionally, I got to connect with a lot of interesting start ups as well as funds with similar interests to ours.  If there are ever opportunities to present in one of your future conferences, I would greatly appreciate the opportunity to do so again. Will definitely keep an eye out for the Sept conference. 

Sonia Weiss, WPSS.bio

We had great experience in 1:1 contacts with the startups via RESI platform last week.  So, for sure, I will be participating in the RESI September event, if my schedule is feasible at that time.

Henry Huang, Autobio Venture Capital

Endeavor Life Science Venture Studio believes that to solve great societal problems requires our portfolio company CEOs to build strong partnerships with industry leaders. The consistently high quality of CEOs and companies that participate in the RESI Summit offers our companies unique partnering opportunities. Life Science Nation RESI Summit is a must go to, preeminent event for our CEOs.

Martin Gershon, Endeavor Venture Funds & Venture Studio

We came to RESI as potential investors, and unexpectedly found many more companies representing significant early-stage opportunities for investment and partnership. The atmosphere was extremely collegial with a chance to meet multiple times within the venue, and unlike BIO, not a zoo. I participated as a judge on a cell and gene therapy panel, and also enjoyed giving feedback to the companies who pitched there, plus got to know some of the other judges after the panel event. This was another unexpected plus to attending the RESI meeting. I strongly recommend this meeting to others.

Barri Blauvelt, Tamer Group (Advisor)

This is my first time attending RESI, and although I missed the opportunity to be there in person in Boston, I must say that the online partnering sessions exceeded my expectations.  I was thoroughly impressed by the quality of the startups and the level of innovation showcased during the event.

Anny Hsu, Taiwania Capital

I have been attending the RESI since 2018, and I find it very useful in that it allows me to meet with many StartUp companies that I would not be able to meet at partnering conferences such as Bio International. In fact, I often attend smaller partnering conferences as well as Bio International, but there are a few StartUp companies that we could only meet at RESI because we could not meet them at those partnering conferences, which is a true testament to the value of RESI. I also benefit from the information on cutting-edge drug discovery research and technology that we can gain from participating in RESI. In addition, it is very beneficial from a long-term perspective that RESI offers a chance for StartUp companies to join RESI so that they can build partnerships with pharmaceutical companies or VC firms and become our future collaboration partners. From this perspective, I hope that StartUp will continue to participate in RESI and deepen its collaboration with us and other pharmaceutical companies and VCs who are also participating in RESI to build the EcoSystem.

Hiroyuki Eda, EA Pharma

I got to know many startups and their promising technologies effectively through the RESI platform. I have been able to meet many of them in person at the RESI conference venues or online meetings, which lead to discussions about investment and partnership.

Yoichi Omae, Asahi Intecc

Who Should Attend

RESI is committed to facilitating conversations that spark early-stage deals in across drugs, devices, diagnostics, and digital health that save lives and change the world through healthcare innovation. To advance the most successful deals, all major players, including both buyers and sellers, are saved a seat at the table. RESI attracts incubators, tech transfer offices, universities, hospitals, research labs and their constituents getting on the radar of investors and channel partners. Biotech, medtech, diagnostics, and digital health companies source global investors and strategic partners, create relationships, and pitch to secure funding from Seed to Series B*.

*Seed ($25K – 2M), Series A ($2 – 10M), Series B ($10 – 50M), and Licensing opportunities;

In RESI 2023 Series

0+
Investors & Strategic Partners Across 10 Different Categories*

Investors get a front-row seat to emerging early-stage companies, with direct insight into product pipelines, licensing opportunities, financing rounds, technologies, and management details in order to find the best fit for their theme.

*The LSN Investor Database covers over 10,000+ active life science investors across the following 10 categories:

  • Angel Groups
  • Corporate Venture Capital
  • Endowments/Foundations
  • Family Office/Private Wealth Funds
  • Government Organizations
  • Hedge Funds
  • Institutional Alternative Investors
  • Large Pharma/ Biotech Companies
  • Private Equity
  • Venture Capital
0+
Start-Ups & Fundraising Executives Including Drugs(Therapeutics), Medical Devices, Diagnostics, Digital Health, and R&D Services to Seeking Seed to Series B Investment

CEOs gain access to investors and strategic partners actively seeking opportunities that match their product set and stage of development through a match-based partnering system, pitch opportunities, and industry expert panels.

Therapeutics

Medical Devices

Diagnostics

Digital Health

R&D Services & Tools

0+
Others (Service Provider, Tech Hub, Regional Organization etc.)

Deal-making is not just a two-way street. The early-stage arena can be challenging to navigate without the help of law firms, broker-dealers, CROs/CMOs, and consulting services to assist in bringing a bright prospect to market.

Sponsorship Benefits

  • Workshop opportunity

  • Exhibit at the conference

  • Free tickets & additional discount rates

  • Logo featured on conference website, social media, marketing promotion, onsite materials etc.

  • Moderate a panel

  • Banner Ads in LSN newsletter

About Organizer: Life Science Nation

Life Science Nation (LSN) has built a global partnering ecosystem featuring healthcare startups and the capital investors, co-development, and licensing partners who seek them. This partnering ecosystem consists of the LSN Global Partnering Campaign Database, Focus on Cures Accelerator, and the world-renowned Redefining Early-Stage Investments (RESI) conference series, which work closely with LSN’s global tech hub network.

Stay Up-to-Date with LSN Newsletters

Stay up-to-date with industry insights, expert interviews, event announcements, and active investor mandates with our three newsletters. Click the logo below to subscribe!

(Daily)

(Weekly)

(Monthly)